GlassScriptPhysician profile
Mohi Alkadri
NPI 1619167855
$20,385.40
in general payments reported to CMS, 2019-2025
30 companies · $531 in 2025
The $531 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,440 · 2020: $8,455 · 2021: $1,217 · 2022: $612 · 2023: $1,306 · 2024: $825 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,558 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,558.19 |
| Education | $103.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $9,055.61 | 2019-2025 | Indigo System |
| Angiodynamics, INC. | $6,673.65 | 2019-2021 | |
| Abiomed | $1,117.39 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $441.48 | 2019-2025 | |
| Boston Scientific Corporation | $398.48 | 2019-2024 | Wavewriter Alpha Prime 16, Coveredge 32, Jetstream Sc |
| Abbott Laboratories | $360.93 | 2023-2024 | Cardiomems, Aveir |
| Viz.Ai, INC. | $232.63 | 2022 | |
| Merck Sharp & Dohme LLC | $232.36 | 2022-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.39 | 2020-2022 | |
| Biotronik INC. | $221.50 | 2019 | |
| Pfizer INC. | $177.70 | 2022-2024 | |
| Medtronic Vascular, INC. | $172.54 | 2019 | |
| Janssen Pharmaceuticals, INC | $161.20 | 2019-2023 | Xarelto |
| Philips North America LLC | $156.45 | 2019-2025 | (Br6) Re Entry, Encore |
| Chiesi USA, INC. | $119.94 | 2021-2024 | Kengreal, Cleviprex |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $104.65 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $104.40 | 2019-2024 | Repatha |
| Shockwave Medical, INC | $70.34 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $55.99 | 2023-2024 | Gore Cardioform Septal Occluder |
| Bard Peripheral Vascular, INC. | $54.88 | 2021-2023 | Venclose Maven Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.11 | 2022-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $32.13 | 2019 | |
| Tactile Systems Technology INC | $29.60 | 2020 | |
| Edwards Lifesciences Corporation | $27.61 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $22.82 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2025 | |
| Teleflex LLC | $19.83 | 2022 | |
| Cardiovascular Systems INC. | $19.70 | 2019 | |
| Smith+Nephew, INC. | $17.51 | 2022 | |
| Medtronic, INC. | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohi Alkadri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.